Venetoclax and Ibrutinib for Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia.
Blood. 2020 Oct 7:blood.2020008608. doi: 10.1182/blood.2020008608. Online ahead of print.
Blood. 2020.
PMID: 33027809
No abstract available.